Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Archer

Showing results (91-100 of 175) with videos related to

Pageof 18
Sort By:
Menopause (New York, N.Y.)|December 26, 2012
Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopauseDavid F Archer, Joann V Pinkerton, Christine J Guico-Pabia, et al.
Journal of Women'S Health (2002)|May 30, 2023
Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring UsersJeffrey T Jensen, David F Archer, Carolyn L Westhoff, et al.
Contraception: X|June 19, 2020
A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimenThomas Kimble, Anne E Burke, Kurt T Barnhart, et al.
Menopause (New York, N.Y.)|December 26, 2012
Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trialJoAnn V Pinkerton, David F Archer, Christine J Guico-Pabia, et al.
Contraception|January 14, 2015
Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pillAndrew M Kaunitz, David Portman, Carolyn L Westhoff, et al.
Contraception|January 15, 2015
New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 studyAndrew M Kaunitz, David Portman, Carolyn L Westhoff, et al.
Obstetrics and Gynecology|June 4, 2005
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal womenSheila Ronkin, Robert Northington, Edmund Baracat, et al.
Contraception|April 28, 2005
Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrelSidney Funk, Michael M Miller, Daniel R Mishell, et al.
Journal of Women'S Health (2002)|December 2, 2017
A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome SymptomDavid F Archer, Thomas D Kimble, F D Yuhua Lin, et al.
Menopause (New York, N.Y.)|April 19, 2017
Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trialJames A Simon, David F Archer, Risa Kagan, et al.
Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Menopause (New York, N.Y.)|December 26, 2012
Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopauseDavid F Archer, Joann V Pinkerton, Christine J Guico-Pabia, et al.
Journal of Women'S Health (2002)|May 30, 2023
Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring UsersJeffrey T Jensen, David F Archer, Carolyn L Westhoff, et al.
Contraception: X|June 19, 2020
A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimenThomas Kimble, Anne E Burke, Kurt T Barnhart, et al.
Menopause (New York, N.Y.)|December 26, 2012
Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trialJoAnn V Pinkerton, David F Archer, Christine J Guico-Pabia, et al.
Contraception|January 14, 2015
Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pillAndrew M Kaunitz, David Portman, Carolyn L Westhoff, et al.
Contraception|January 15, 2015
New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 studyAndrew M Kaunitz, David Portman, Carolyn L Westhoff, et al.
Obstetrics and Gynecology|June 4, 2005
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal womenSheila Ronkin, Robert Northington, Edmund Baracat, et al.
Contraception|April 28, 2005
Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrelSidney Funk, Michael M Miller, Daniel R Mishell, et al.
Journal of Women'S Health (2002)|December 2, 2017
A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome SymptomDavid F Archer, Thomas D Kimble, F D Yuhua Lin, et al.
Menopause (New York, N.Y.)|April 19, 2017
Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trialJames A Simon, David F Archer, Risa Kagan, et al.
Pageof 18